Table 1. The physical properties and permeability characteristic of model drugs.
Compound | Molecular formula | Mw | Water solubility (mg/)a | pK a b | %FAc | P e(10−6 cm/s)d | ||
---|---|---|---|---|---|---|---|---|
C8 | C10 | C12 | ||||||
Amoxicillin | C16H25N3O8S | 419.46 | 3430 | 2.6, 7.31, 9.53 | 93 | 4.6±0.4 | 5.3±0.3 | 5.7±0.4 |
Atenolol | C14H22N2O3 | 266.39 | 1.33×104 | 9.54 | 54 | 3.8±0.4 | 5.2±0.4 | 5.9±0.5 |
Chloroamphenicol | C11H12Cl2N2O5 | 323.13 | 2500 | 4.3 | 90 | 8.8±0.2 | 9.8±0.3 | 14.6±0.3 |
Cimetidine | C10H16N6S | 252.34 | 9380 | 7.23 | 85 | 2.6±0.4 | 2.8±0.3 | 3.2±0.3 |
Famotidine | C8H15N7O2S3 | 337.45 | 1000 | 7.24, 11.19 | 40 | 2.7±0.3 | 2.8±0.2 | 3.2±0.4 |
Ibuprofen | C13H18O2 | 206.28 | 21 | 4.59 | 95 | 13.9±0.5 | 14.5±0.5 | 16.7±0.4 |
Metformin Hydrochloride | C4H11N5·HCl | 165.63 | Freely soluble | 12.4 | 55 | 2.4±0.4 | 2.9±0.3 | 3.4±0.2 |
Metoprolol Tartrate | (C15H25NO3)2·C4H6O6 | 682.82 | 1.69×104 | 9.56 | 95 | 9.2±0.6 | 10.3±0.5 | 11.7±0.5 |
Norfloxacin | C15H18N3O3F | 319.34 | 1.78×105 | 6.26, 8.63 | 35 | 0.9±0.1 | 1.0±0.1 | 1.0±0.1 |
Ranitidine | C13H24N4O3S· | 314.37 | 24.7 | 8.2 | 55 | 1.2±0.1 | 1.4±0.1 | 1.5±0.1 |